a, Schematic representation showing the conversion of VFG culture to pancreatic and hepatic expansion. The figure illustrates the generation of PDX1−eGFP positive (PDX1+) and negative (PDX1−) cells from VFG culture after BMP4 withdrawal and subsequent stimulation with FGF. b-c, Flow cytometry of eGFP expression (b) or intracellular PDX1 (c) for HUES4 wild type (grey), PDX1−eGFP reporter (purple) in VFG culture, and the reporter following BMP4 withdrawal (green). Fractions of eGFP+ or PDX1+ were gated and percentages are shown. Flow Cytometry plot represents three independent experiments. d, Left: UMAP visualization of 526 cells isolated from mock-treated VFG (blue), VFG cells grown in the absence of BMP4 (red), and transient pancreatic induction by FGF2 simulation (green). Right: UMAP visualization of Seurat clustering from the samples described on the left. e, Representative bright-field (top) and fluorescent (bottom) images for the PDX1-eGFP reporter VFGs (left) or following BMP4 withdrawal (right), and then treated with FGF2, FGF7, or FGF10. Images represent three independent experiments. Scale bar = 50 μm. f, Flow cytometry of eGFP expression for the conditions described in (e), including mock-treated cells. Percentages of PDX1+ cells were shown in the rectangle boxes of each histogram. Flow Cytometry plots represent three independent experiments. g, PDX1+ cells form 3D spheres and expand as pancreatic spheroids (Top). PDX1−cells form 2D clusters and expand as hepatic organoids (bottom). Images represent three independent experiments. Scale bar = 50 µm. h-i, Relative fold change in mRNA of pancreatic markers (PDX1, SOX9, and ONTCUT1) (h) and hepatic markers (AFP, ALB, and SERPINA1) (i) in the VFGs and VFG-derived cell types (as described in a and g). Expression is normalized with ACTB. Data are represented as mean ± SEM (N = 3 independent experiments). **P < 0.01, ***P < 0.001, ****P < 0.0001 (one-way ANOVA Dunnett’s multiple comparison test compared with VFG).
Source data